Skip to main content

The first-in-class disease-modifying drug for chronic airway disorders

Searching for OpenAIRE data...


Azithromycin ameliorates sulfur dioxide-induced airway epithelial damage and inflammatory responses

Author(s): Joelsson, J.P., Kricker, J.A., Arason, A.J. et al.
Published in: Respiratory Research, 21, Article no 233, 2020
Publisher: Springer Nature
DOI: 10.1186/s12931-020-01489-8

Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development

Author(s): Jennifer A. Kricker, Clive P. Page, Fridrik Runar Gardarsson, Olafur Baldursson, Thorarinn Gudjonsson and Michael J. Parnham
Published in: Pharmacological Reviews, October 2021, 73 (4), 2021, Page(s) 233-262, ISSN 0031-6997
Publisher: American Society for Pharmacology and Experimental Therapeutics
DOI: 10.1124/pharmrev.121.000300